| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.005 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |